Publications
Publications
Show Results For
- All HBS Web
(893)
- Faculty Publications (220)
←
Page 11 of 220
Results
- Article
What Will Be Needed for the New GI Fellowship Match to Succeed?
By: Muriel Niederle, Deborah D. Proctor and Alvin E. Roth
- June 2005
- Article
The Collapse of a Medical Labor Clearinghouse (and why such failures are rare)
By: C. Nicholas McKinney, Muriel Niederle and Alvin E. Roth
- December 2004
- Article
Learning from Failure in Health Care: Frequent Opportunities, Pervasive Barriers.
By: A. C. Edmondson
- May 2004
- Article
The Role of Information in Medical Markets: An Analysis of Publicly Reported Outcomes in Cardiac Surgery
By: David Cutler, Robert S. Huckman and Mary Beth Landrum
- November 2001
- Case
Aventis CropScience and StarLink Corn
By: Ray A. Goldberg and James M Beagle
Aventis CropScience responds to the discovery of an unapproved corn variety in food supplies and draws lessons for the company, industry, and governments. View Details
- April 1993 (Revised November 1994)
- Case
Chiron Corp.
Pablo Valenzuela, vice president of R&D at Chiron Corp., faces several choices for how to allocate scarce resources across several promising projects. These choices will determine Chiron's position in several emerging biotechnology and diagnostic markets, including... View Details
- July 1992 (Revised March 1994)
- Teaching Note
Beverly Hospital and North Shore Birth Center TN
- October 1991 (Revised August 2000)
- Case
Becton Dickinson & Company: VACUTAINER Systems Division (Condensed)
By: V. Kasturi Rangan and Frank V. Cespedes
Becton Dickinson, a phenomenally successful company with an 80% market share in the blood collection needles and syringes market faces a change in the customer buying environment (cost containment pressures at hospitals). This forces a reevaluation of the company's... View Details
- October 1990 (Revised April 1991)
- Case
RU 486 (A)
Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details
- April 1990 (Revised January 1993)
- Case
Ad Council's AIDS Campaign (A): Advertising Strategy
By: V. Kasturi Rangan and Janet Montgomery
Ad Council wished to run an educational campaign aimed at preventing the spread of AIDS. They were challenged to find acceptable ways to address this very sensitive subject matter--ways that the media and the public would approve. One of the big challenges was to make... View Details
- March 1990 (Revised March 1992)
- Case
New York Against AIDS (A): The Saatchi & Saatchi Compton Advertising Campaign
By: V. Kasturi Rangan and Sohel Karim
Describes the background leading to the development of an advertising campaign to help prevention of AIDS in New York City. The three television networks, however, for various reasons reject the campaign, to the dismay of Saatchi & Saatchi executives. View Details
- August 1986 (Revised February 1991)
- Supplement
Population Services International: The Social Marketing Project in Bangladesh, Video
Population Services International, a not-for-profit agency founded to promote family planning information and to market birth control products, had an agreement with the government of Bangladesh to conduct a social marketing program using modern marketing techniques to... View Details
- September 1985 (Revised July 2007)
- Case
Population Services International: The Social Marketing Project in Bangladesh
Population Services International (PSI) was a not-for-profit agency founded to disseminate family planning information and to market birth control products, primarily in less developed countries seeking to curb their population explosions. In 1976, PSI concluded an... View Details
- March 1985 (Revised May 1993)
- Case
North Shore Birth Center
- Article
The Efficacy of a Comprehensive Health Project: An Empirical Analysis
By: Robert S. Kaplan, Lester Lave and Samuel Leinhardt
- Teaching Interest
Managing Health Care Delivery
Complex patient needs, expensive technology innovations, and constrained resources are putting a heavy strain on health care delivery—and exposing vulnerable populations to greater risk.
Managing Health Care Delivery helps you build the capabilities to... View Details
- Teaching Interest
Managing Health Care Delivery - Executive Education
While delivering patient care has always been a primary goal of health care organizations, financial outcomes have long been the metric by which success is measured. Increasingly, however, health care leaders are being held accountable for... View Details
- Research Summary
Overview
By: Robert S. Kaplan
Kaplan introduced time-driven activity-based costing (TDABC) to provide the cost component in Michael Porter's Value Based Health Care framework of delivering superior patient outcomes at lower societal cost. TDABC is becoming the global standard for health care... View Details
- 5 Jan 2012
- Other Presentation
Value-Based Health Care Delivery: Outcomes Measurement and Reimbursement
Keywords: Health
- Forthcoming
- Article
When Should Public Programs Be Privately Administered? Theory and Evidence from the Paycheck Protection Program
By: Alexander W. Bartik, Zoë Cullen, Edward L. Glaeser, Michael Luca, Christopher Stanton and Adi Sunderam
What happens when public resources are allocated by private companies whose objectives may be
imperfectly aligned with policy goals? We study this question in the context of the Paycheck
Protection Program (PPP), which relied on private banks to disburse aid to small... View Details
- ←
- 11